EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 38 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $85,000 | +51.8% | 8,502 | +49.1% | 0.00% | +100.0% |
| Q2 2022 | $56,000 | +86.7% | 5,702 | +89.4% | 0.00% | 0.0% |
| Q1 2022 | $30,000 | -96.2% | 3,010 | -96.2% | 0.00% | -92.9% |
| Q3 2021 | $791,000 | -2.8% | 79,779 | 0.0% | 0.01% | +7.7% |
| Q2 2021 | $814,000 | -1.8% | 79,779 | -3.2% | 0.01% | +8.3% |
| Q1 2021 | $829,000 | -65.5% | 82,379 | -63.5% | 0.01% | -86.0% |
| Q4 2020 | $2,406,000 | – | 225,685 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|